Toke-lahoma & The Wilds of NYC
The Gold Rush atmosphere is because everyone is expecting the arrival of bigger, better-funded, publicly-traded cannabis companies, accompanied by their networks of retail stores.
Select Page
by C. Scott McMillin | Jun 2, 2022 | In the News | 0 |
The Gold Rush atmosphere is because everyone is expecting the arrival of bigger, better-funded, publicly-traded cannabis companies, accompanied by their networks of retail stores.
by C. Scott McMillin | May 30, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | May 26, 2022 | In the News | 0 |
by C. Scott McMillin | May 23, 2022 | Public Health | 0 |
by C. Scott McMillin | May 16, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | Feb 17, 2022 | Public Policy | 0 |
by C. Scott McMillin | Feb 7, 2022 | In the News | 0 |
A functioning pill mill can be extraordinarily lucrative for those who own or operate them. The profits go untaxed, remember.
Read Moreby C. Scott McMillin | Jan 17, 2022 | In the News | 0 |
In COVID terms, it’s as contagious as omicron, as fatal as delta. And targeted at the young, making use of their favorite platforms.
Read Moreby C. Scott McMillin | Dec 27, 2021 | Public Policy | 0 |
…it’s foolish to expect an industry built around making, distributing, and selling (for immense profit) abusable substances to regulate themselves.
Read Moreby C. Scott McMillin | Nov 29, 2021 | In the News | 0 |
If so many players were involved, how can drug makers bear primary responsibility? Even if to the layperson’s mind, they richly deserve it.
Read Moreby C. Scott McMillin | Oct 28, 2021 | Addictive Substances | 0 |
Some genuinely bad news: a larger-than-usual share of the fakes are likely to exceed the two-milligram threshold for a potentially lethal dose of fentanyl. As many as two in five, according to DEA.
Read Moreby C. Scott McMillin | Sep 6, 2021 | In the News | 0 |
Now this really sounds like what we heard from Purdue Pharma in the early days of the Oxycontin epidemic.
Read Moreby C. Scott McMillin | Jul 22, 2021 | Public Policy | 0 |
“Holy crap! What happened?” the public demands. Followed by “Who’s to blame?” Not us, insist the makers and distributors.
Read Moreby C. Scott McMillin | Jul 1, 2021 | Addictive Substances | 0 |
Maybe less potent (we hope), but for now, it’s sitting there on the convenience store counter, in brightly colored packages with kid-friendly names.
Read Moreby C. Scott McMillin | Jun 10, 2021 | Addictive Substances | 0 |
It probably wouldn’t occur to the average American to ask the local casino for information on the risks of gambling, but cannabis consumers seem willing to rely on industry websites for the truth about that drug.
Read Moreby C. Scott McMillin | Jun 7, 2021 | In the News | 0 |
Instead, they seem to rely on deep pockets, sophisticated lobbying, and battalions of attorneys to absorb the penalties and minimize the damage done to those profits.
Read Moreby C. Scott McMillin | May 10, 2021 | Addictive Substances, Public Policy | 0 |
Cannabusinesses and their investor groups are agitating for relaxation of some restrictions, particularly around opening stores in certain areas, and on advertising.
Read Moreby C. Scott McMillin | Mar 18, 2021 | Prevention, Public Health, Public Policy | 0 |
On a recent show, comedian John Oliver addressed the prospect of a future virus pandemic that...
Read More